US2016367801A1PendingUtilityA1
Method and Apparatus for Optimization of Cardiac Resynchronization Therapy Using Vectorcardiograms Derived from Implanted Electrodes
Est. expirySep 11, 2033(~7.1 yrs left)· nominal 20-yr term from priority
A61N 1/3627A61N 1/371A61N 1/3684A61N 1/36507A61N 1/3686A61N 1/36842A61N 1/36843A61N 1/365A61B 5/04011A61B 5/341
38
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A cardiac resynchronization pacemaker and a method of adjusting the pacemaker. The method includes deriving a vectorcardiogram from implanted electrodes (D-VCG), analyzing the D-VCG, deriving optimal CRT pacing parameters from the analysis of the D-VCG, and adjusting the CRT pacemaker according to the derived parameters. The pacemaker may include a processor configured to perform the method.
Claims
exact text as granted — not AI-modified1 . A method of adjusting a cardiac resynchronization (CRT) pacemaker of the type having the capabilities of left ventricular pacing and atrial sensing, comprising:
deriving a vectorcardiogram from implanted electrodes (D-VCG); analyzing the D-VCG; deriving optimal CRT pacing parameters from the analysis of the D-VCG; and adjusting the CRT pacemaker according to the derived parameters.
2 . A method according to claim 2 further comprising storage of the D-VCG for diagnostic purposes.
3 . A method according to claim 1 , wherein the derived pacing parameters include an atrial to left ventricular (A-LV) and an atrial to right ventricular (A-RV) pacing interval.
4 . A method according to claim 1 , wherein the derived pacing parameters include an atrial to left ventricular (A-LV) pacing interval.
5 . A method according to claim 1 wherein the derived parameters include an optimal electrode location.
6 . A method according to claim 1 wherein the analysis of the D-VCG comprises measurement of QRS vector area (QRSVarea).
7 . A method according to claim 6 wherein the optimal pacing parameters comprise those that result in a minimum QRSVarea.
8 . A method according to claim 1 wherein the analysis of the D-VCG comprises measurement of QRS vector perimeter.
9 . A method according to claim 1 wherein the analysis of the D-VCG comprises measurement of QRS vector amplitude.
10 . A method according to claim 1 further comprising employing the obtained D-VCG to detect loss of capture, due to technical failure of the pacemaker or lead, irregular heart beats or altering cardiac conduction properties.
11 . A method according to claim 1 wherein analysis of the D-VCGs comprises identification of start and endpoints of QRS complexes.
12 . A method according to claim 1 wherein the analysis of D-VCGs comprises performing the analysis in conjunction with delivery of CRT pacing using different pacing parameters.
13 . A method according to claim 1 wherein the analysis of D-VCGs comprises performing the analysis in conjunction with delivery of CRT pacing using different pacing electrode configurations.
14 . A cardiac resynchronization (CRT) pacemaker of the type having the capabilities of left ventricular pacing and atrial sensing, and comprising a set of implanted electrodes, comprising:
a processor configured to:
a) derive a vectorcardiogram from the implanted electrodes (D-VCG);
b) analyze the D-VCG;
c) derive optimal CRT pacing parameters from the analysis of the D-VCG; and
d) control delivery of CRT pacing according to the derived parameters.
15 . A device according to claim 14 further comprising memory configured to store the D-VCG for diagnostic purposes.
16 . A device according to claim 14 , wherein the derived pacing parameters include an atrial to left ventricular (A-LV) and an atrial to right ventricular (A-RV) pacing interval.
17 . A method according to claim 14 , wherein the derived pacing parameters include an atrial to left ventricular (A-LV) pacing interval.
18 . A method according to claim 14 wherein the derived parameters include an optimal electrode location.
19 . A method according to claim 14 wherein the analysis of the D-VCG comprises measurement of QRS vector area (QRSVarea).
20 . A method according to claim 19 wherein the optimal pacing parameters comprise those that result in a minimum QRSVarea.
21 . A method according to claim 14 wherein the analysis of the D-VCG comprises measurement of QRS vector perimeter.
22 . A method according to claim 14 wherein the analysis of the D-VCG comprises measurement of QRS vector amplitude.
23 . A method according to claim 14 further comprising employing the obtained D-VCG to detect loss of capture, due to technical failure of the pacemaker or lead, irregular heart beats or altering cardiac conduction properties.
24 . A method according to claim 14 wherein analysis of the D-VCGs comprises identification of start and endpoints of QRS complexes.
25 . A method according to claim 14 wherein the analysis of D-VCGs comprises performing the analysis in conjunction with delivery of CRT pacing using different pacing parameters.
26 . A method according to claim 41 wherein the analysis of D-VCGs comprises performing the analysis in conjunction with delivery of CRT pacing using different pacing electrode configurations.Join the waitlist — get patent alerts
Track US2016367801A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.